Table 1.
Sex | male: female | 48:76 |
Age (yrs) | median; IQR | 38.5; 48-28 |
Age at onset of Seizures (yrs) | median; IQR | 12; 4–22 |
Frequency of Seizures (per month) | median; IQR | 2; 1–6 |
Duration of Epilepsy (yrs) | median; IQR | 22; 13–33 |
Anti-Epileptic Drug Trials | median; IQR | 3; 2–5 |
Unilateral Temporal Lobe Hypometabolism | yes:no | 61:64 |
Extratemporal Hypometabolism | yes:no | 19:25 |
Mesiotemporal Sclerosis on MRI | yes:no | 57:67 |
EEG localize to one temporal lobe | yes:no | 73:51 |
Surgical Candidate | yes:no:unknown | 50:69:5 |
Length of Follow-Up* (months) | median; IQR | 24; 6.5–42 |
ILAE* (at last follow-up) | median; IQR | 1; 1–2 |
IQR, inter-quartile range (25–75%); yrs, years; ILAE, International League Against Epilepsy;
n=34 (only patients that received surgery and had follow-up)